Status:
UNKNOWN
Study of Bioactive Glass-ceramic Intervertebral Spacer (Bonglass-SS) in Posterior Lumbar Interbody Fusion
Lead Sponsor:
BioAlpha Inc.
Conditions:
Degenerative Disk Disease
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
The goal of this study is to compare Bonglass-SS with titanum cage.
Eligibility Criteria
Inclusion
- 30\~80 aged patients needed single-level posterior Interbody fusion at L1\~S1
- A subject who provided written informed consent to participate in this study
Exclusion
- Patitents with BMD T-score \< -3.0
- Women who are pregnant or plan to be pregnant within 3 years
- Patient with malignant tumor
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2013
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT01439464
Start Date
October 1 2010
End Date
June 1 2013
Last Update
September 23 2011
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Dongguk University Medical Center
Goyang-si, Gyeonggi-do, South Korea
2
Seoul National University Bundang Hospital
Sungnam-Si, Gyeonggi-do, South Korea
3
Seoul National University Hospital
Seoul, South Korea
4
Seoul National University Seoul Metropolitan Boramae Medical Center
Seoul, South Korea